research Transient hair loss in patients with chronic spontaneous urticaria treated with omalizumab
This case report details a young female patient's experience of transient hair loss after starting omalizumab (anti-IgE) for chronic urticaria, noting that she continued the treatment for 10 months with positive outcomes despite this side effect.